Healthcare · Pharmaceuticals & Biotechnology
No company profile on record yet.
| Fiscal year | Mar 26 | Mar 25 | Mar 24 | Mar 23 |
|---|---|---|---|---|
| Total income (before exceptional items) | 5,445† | 5,493† | 4,592† | — |
| Net profit | 700 | 691 | 391 | 69 |
₹ Crore. † Summed from the four quarterly filings of that fiscal year.
Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.
| Name | Designation | Term end |
|---|---|---|
| Nandini Piramal | Executive Director | June 30, 2026 |
| Peter DeYoung | Executive Director | June 30, 2026 |
| Vivek Valsaraj | Executive Director | June 30, 2026 |
| Amit Soni | Independent Director | June 30, 2026 |
| Jairaj Purandare | Independent Director | June 30, 2026 |
| Peter Stevenson | Independent Director | June 30, 2026 |
| Sridhar Gorthi | Independent Director | June 30, 2026 |
| Vibha Paul Rishi | Independent Director | June 30, 2026 |
| Amit Jain | Non-Executive Director | June 30, 2026 |
| Nathalie Leitch | Non-Executive Director | June 30, 2026 |
Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.
